Hemcheck
Manufacturing · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Universitetsgatan 2, Karlstad, Vaermland...Phone Number
+46 761088191Website
www.hemcheck.seRevenue
$6.4 MillionIndustry
About Hemcheck
Is Hemcheck your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Hemcheck recently announced quarterly report
Check if Hemcheck has recently received funding, and reach out quickly before it becomes old news!
Hemcheck, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Hemcheck launches new products
Check out if Hemcheck is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Hemcheck has new funding data
Click to see if Hemcheck had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Hemcheck
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Hemcheck is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Hemcheck is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Hemcheck.
Hemcheck Tech Stack
A closer look at the technologies used by Hemcheck
Hemcheck News & Media
Hemcheck has received a first order from its distributor Astemed
Hemcheck has received a first smaller order from Astemed, which is the company's distributor in the United Arab Emirates. The order concerns instruments and v-Test and is of minor economic value. - It is very positive with a first order from Astemed and the United Arab Emirates. There is a very interesting potential in the regional market, and we of course hope that this is the first in a series of orders from there, saysHemcheck submits a formal application to Nasdaq for a decision on continued listing before the implementation of the Bio Vitos agreement
Hemcheck has today submitted the formal application to Nasdaq to obtain a conditional approval for continued listing in connection with the implementation of the BioVitos agreement. The company hope to receive a decision from Nasdaq within about a month. More about the possible Transaction If the deal is completed, it will, as previously communicated, mean that Hemcheck will acquire capital and IP rights relating to the use of iron succinate for the treatment of patientsAdditional follow up order from the Foundation for Innovative New Diagnostics (FIND)
Hemcheck Sweden AB has received a new follow up order from the Foundation for Innovative New Diagnostics (FIND) regarding delivery of reader and one-time tests (v-Test). The order is worth over 10,000 EUR. -Our collaboration with FIND continues, which is very positive. We continue see good potential in the collaboration where we can help and strengthen the quality work within their large network of healthcare facilities and biobanks, says Joen Averstad, acting CEO of Hemcheck.Hemcheck has received a first order from the university hospital Charité in Berlin
Hemcheck has received a first small order from the university hospital Charité in Berlin. Charité is one of the largest university hospitals in Europe with a budget of approximately EUR 2.3 billion. The order concerns bgs-Test and is of lower economic value. - It is very positive with a first order from Charité. The hospital is a very large university hospital and a reference hospital for many other possible customers both in Germany and internationally.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Hemcheck
Hemcheck Sweden AB specializes in innovative medical solutions aimed at improving healthcare workflows, reducing costs, and enhancing patient safety. Their flagship product, Helge, includes a series of single-use tests designed to quickly and accurately detect hemolyzed blood samples at the point of care. The company targets healthcare providers an... Read More